UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000030816
Receipt number R000034267
Scientific Title Asian, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tamoxifen With or Without Palbociclib +/- Goserelin in Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Date of disclosure of the study information 2018/01/15
Last modified on 2023/11/17 17:38:57

No. Disposal Last modified on Item of update
1 Insert 2018/01/15 14:13:31
2 Update 2018/02/07 17:35:09 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
IND to MHLW
Institutions
3 Update 2018/02/09 15:11:13 Recruitment status
Anticipated trial start date
4 Update 2018/02/22 17:15:21 Institutions
5 Update 2018/03/01 09:13:17 Institutions
6 Update 2018/03/19 20:40:02 Institutions
7 Update 2018/05/14 17:13:34 Institutions
8 Update 2018/05/18 16:07:46 Institutions
9 Update 2018/05/23 18:21:49 Institutions
10 Update 2018/07/12 20:16:04 Institutions
11 Update 2018/07/26 16:04:51 Institutions
12 Update 2018/11/22 12:44:12 Institutions
13 Update 2019/07/19 06:35:27 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
14 Update 2019/07/19 08:46:41 Recruitment status
Date of IRB
Last follow-up date
15 Update 2019/07/19 08:49:05 Number of participants that the trial has enrolled
16 Update 2019/07/30 11:20:37 Institutions
17 Update 2020/06/03 13:19:53 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
IND to MHLW
18 Update 2023/11/17 17:38:57 Last follow-up date